GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Quick Ratio

BIOA (Bioage Labs) Quick Ratio : 17.63 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Bioage Labs's quick ratio for the quarter that ended in Sep. 2024 was 17.63.

Bioage Labs has a quick ratio of 17.63. It generally indicates good short-term financial strength.

The historical rank and industry rank for Bioage Labs's Quick Ratio or its related term are showing as below:

BIOA' s Quick Ratio Range Over the Past 10 Years
Min: 0.44   Med: 11.81   Max: 17.63
Current: 17.63

During the past 2 years, Bioage Labs's highest Quick Ratio was 17.63. The lowest was 0.44. And the median was 11.81.

BIOA's Quick Ratio is ranked better than
97.39% of 1035 companies
in the Drug Manufacturers industry
Industry Median: 1.4 vs BIOA: 17.63

Bioage Labs Quick Ratio Historical Data

The historical data trend for Bioage Labs's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Quick Ratio Chart

Bioage Labs Annual Data
Trend Dec22 Dec23
Quick Ratio
4.78 0.44

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Quick Ratio Get a 7-Day Free Trial - 0.44 11.81 12.61 17.63

Competitive Comparison of Bioage Labs's Quick Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioage Labs's Quick Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Bioage Labs's Quick Ratio falls into.


Bioage Labs Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Bioage Labs's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(25.306-0)/58.168
=0.44

Bioage Labs's Quick Ratio for the quarter that ended in Sep. 2024 is calculated as

Quick Ratio (Q: Sep. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(336.467-0)/19.08
=17.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs  (NAS:BIOA) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

Bioage Labs Quick Ratio Related Terms

Thank you for viewing the detailed overview of Bioage Labs's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Quick Ratio
Comparable Companies
Traded in Other Exchanges
N/A
Address
1445A South 50th Street, Richmond, CA, USA, 94804
Website
https://www.bioagelabs.com
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.